Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ecole Polytechnique Fédérale de Lausanne | OTHER |
| Clinique Romande de Readaptation | NETWORK |
Not provided
Not provided
Not provided
Not provided
Not provided
The present study aims at investigating (i) the feasibility in chronic stroke of using a dedicated virtual reality (VR) based system that embeds real-time 3D motion capture and embodied visual feedback to deliver functional exercises designed for training of impaired upper limb motor skills, (ii) whether chronic stroke survivors improve in functional outcomes in the upper limb when exposed to intensive VR-based therapy, and (iii) safety and tolerance to such a technology. The investigators hypothesize that intensive VR-based rehabilitation may lead to high rehabilitation doses and functional improvement in chronic stroke.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MindMotion PRO | Experimental | The training sessions consist of virtual reality based rehabilitation exercises using the MindMotion PRO device. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MindMotion PRO | Device | Patients will receive five weeks of therapy with 2 sessions (minimum) per week lasting for 45-60 minutes each minimum. The training sessions are based on the MindMotion PRO's virtual reality exercises. |
| Measure | Description | Time Frame |
|---|---|---|
| Rehabilitation dose: goal-directed movements (i.e. number of intended movements to achieve a task) | Rehabilitation dose: goal-directed movements (i.e. number of intended movements to achieve a task) | 5 weeks |
| Training intensity: number of goal-directed movements per minute of effective training time. | Training intensity: number of goal-directed movements per minute of effective training time. | 5 weeks |
| Change in Upper limb function assessed with Fugl-Meyer Assessment for Upper Extremity (FMA-UE) | Fugl-Meyer Assessment for Upper Extremity (FMA-UE) | At baseline, 5 weeks (post intervention) and 9 weeks (follow-up) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Functional Independence Measure (FIM) | At baseline, 5 weeks (post intervention) and 9 weeks (follow-up) | |
| Change in kinematic metrics/goniometry (active range of motion). | At baseline, 5 weeks (post intervention) and 9 weeks (follow-up) |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Center for Neuroprosthetics-Valais (EPFL) at Clinique Romande de Réadaptation | Sion | Valais | Switzerland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29149855 | Derived | Perez-Marcos D, Chevalley O, Schmidlin T, Garipelli G, Serino A, Vuadens P, Tadi T, Blanke O, Millan JDR. Increasing upper limb training intensity in chronic stroke using embodied virtual reality: a pilot study. J Neuroeng Rehabil. 2017 Nov 17;14(1):119. doi: 10.1186/s12984-017-0328-9. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000068079 | Motor Disorders |
| D020521 | Stroke |
| ID | Term |
|---|---|
| D001523 | Mental Disorders |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Change in Modified Medical Research Council Scale (mMRCS) | At baseline, 5 weeks (post intervention) and 9 weeks (follow-up) |
| Change in Visual Analog Scale (VAS) for Pain | At baseline, 5 weeks (post intervention) and 9 weeks (follow-up) |
| Safety and Acceptance of Technology assessed with a questionnaire | Participants will answer a questionnaire to evaluate following aspects:
| 5 weeks |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |